Due to a production error, an author name was incorrectly written as “Y. Maurice II Morillon.” The correct name is “Y. Maurice Morillon II.” The publisher apologizes for this mistake. The original article has been updated.
. 2020 Jul 24;10:1548. doi: 10.3389/fonc.2020.01548
Erratum: The Use of a Humanized NSG-β2m−/− Model for Investigation of Immune and Anti-tumor Effects Mediated by the Bifunctional Immunotherapeutic Bintrafusp Alfa
Frontiers Production Office1,*
1Frontiers Media SA, Lausanne, Switzerland
Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland
✉
*Correspondence: Frontiers Production Office production.office@frontiersin.org
This article was submitted to Cancer Immunity and Immunotherapy, a section of the journal Frontiers in Oncology
Received 2020 Jul 17; Accepted 2020 Jul 20; Collection date 2020.
Keywords: humanized mouse, NSG-β2m−/−, bintrafusp alfa, immunotherapy, TGF-β
Copyright © 2020 Frontiers Production Office.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
PMCID: PMC7393614 PMID: 32793505